A-717

N/A

Report date: 2025/01/26 18:05:06

Base Information

Drug NameA-717
Drug Alias NamemAb, A-1717monoclonal antibody A-717 (Exocell)mAb A-717 (Exocell)mAb A-717 (Glycadia)A-717
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusDiabetic NephropathiesDiabetic Retinopathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlycadia Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlycadia Inc
Inactive CompaniesN/A
Active IndicationsDiabetic NephropathiesDiabetic RetinopathyDiabetic Neuropathies
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A